This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LOUIS DAILY, M.D.; WILLIAM S. TUTTLE, M.D.

Arch Ophthalmol. 1961;65(3):410-414.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In recent years there has accumulated considerable clinical and experimental evidence which shows that specific proteolytic enzymes can act as potent anti-inflammatory agents.

Review of the Literature

Gordon et al. (1957)¹ induced inflammation in rabbits by the subconjunctival instillation of mustard oil. The intravenous administration of streptokinase-streptodornase preparations prior to the elicitation of the inflammation was shown to be effective in decreasing the severity of the reaction produced. When purified streptodornase was used alone, the reaction of the treated animals did not differ from that of the controls. When streptokinase purified by chromatography was employed, a definite inhibition of inflammation was observed. All effective antiedema concentrations of streptokinase produced demonstrable fibrinolytic responses in the rabbit.

Doses of heparin sufficient to render the blood incoagulable during the experimental period were found to be ineffective in reducing the degree of edema produced. Consequently, it must be assumed that fibrin deposition is . . . [Full Text PDF of this Article]

Author Affiliations
Houston, Texas

From the Division of Ophthalmology, Baylor College of Medicine, Houston, Texas.; Suite 1517, Medical Towers Bldg., Houston 25, Texas.

Footnotes
Submitted for publication Oct. 10, 1960.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?